European Journal of Clinical Microbiology & Infectious Diseases Template
Write in a clean editor, then format for European Journal of Clinical Microbiology & Infectious Diseases in one click — DocuGuru applies the official Springer Nature template with superscript references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the European Journal of Clinical Microbiology & Infectious Diseases format
European Journal of Clinical Microbiology & Infectious Diseases is a peer-reviewed journal published by Springer Nature, covering Bacterial Identification and Susceptibility Testing, Antibiotic Resistance in Bacteria, Antimicrobial Resistance in Staphylococcus.
| Publisher | Springer Nature |
|---|---|
| Reference style | Superscript numbered (Nature) Superscript — small raised numerals in the text 1. Smith, A., Jones, B. & Lee, C. A representative article title. European Journal of Clinical Microbiology & Infectious Diseases 12, 45–58 (2023).
Formats any DOI in European Journal of Clinical Microbiology & Infectious Diseases style. No sign-up. |
| Publishes research in | Bacterial Identification and Susceptibility Testing Antibiotic Resistance in Bacteria Antimicrobial Resistance in Staphylococcus Pneumonia and Respiratory Infections Streptococcal Infections and Treatments |
| ISSN | 0934-9723 |
| Citation impact (2-yr) | 2.95 |
| h-index | 161 |
| i10-index | 6,824 |
| Total citations | 291,752 |
| Article processing charge | $4,390 |
| Top institutions publishing here | Inserm |
| Journal website | www.springer.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in European Journal of Clinical Microbiology & Infectious Diseases per year
Citation impact of European Journal of Clinical Microbiology & Infectious Diseases by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in European Journal of Clinical Microbiology & Infectious Diseases
In a preliminary clinical study, we observed that the combination of hydroxychloroquine and azithromycin was effective against SARS-CoV-2 by shortening the duration of viral load in Covid-19 patients. It is of paramount importance to define when a treated patient can be considered as no longer contagious. Correlation between successful isolation of virus in cell culture…